Sonidegib

Sonidegib is a prescription medication used to treat adults with a type of skin cancer called basal cell carcinoma. It works by blocking a protein that helps cancer cells to grow and divide. This helps to slow or stop the growth of cancer cells. Sonidegib is taken orally once daily. Common side effects include diarrhea, nausea, muscle spasms, hair loss, and fatigue.

Sonidegib is a medication specifically designed to target a type of skin cancer called basal cell carcinoma (BCC). Here's a closer look at its key features:

Main Use:

• Treatment of advanced basal cell carcinoma (BCC) in adults. This includes:
  • BCC that has recurred (come back) after surgery or radiation therapy.
  • BCC that cannot be treated effectively with surgery or radiation.

How it Works:

• Sonidegib belongs to a drug class called hedgehog pathway inhibitors. Cancerous cells often have abnormal signaling pathways that fuel their growth. The hedgehog pathway is one such pathway involved in BCC development.
• Sonidegib acts by blocking a protein called smoothened, which is a critical component of the hedgehog pathway. By inhibiting smoothened, Sonidegib disrupts the signaling process and helps slow or stop the growth of BCC tumors.

Dosage and Administration:

• Sonidegib comes in capsule form and is typically taken orally once daily on an empty stomach.

Important Notes:

• Sonidegib is not a first-line treatment for BCC. Doctors usually reserve it for more advanced cases.
• Sonidegib can cause side effects, some of which can be serious. It's crucial to be under the supervision of a healthcare professional while taking this medication.
• Sonidegib can interact with other medications. It's important to disclose all medications you're taking to your doctor before starting Sonidegib.

Brand Name:

• Odomzo

Additional Information:

• Sonidegib is a prescription medication, and this is just a general overview. It's vital to consult a doctor to determine if Sonidegib is suitable for your specific case and discuss potential benefits and risks.
• Since Sonidegib is a targeted therapy, your doctor may recommend genetic testing of your tumor to confirm if it has mutations that Sonidegib can target effectively.